Beidouxing ENT Hospital Secures Tens of Millions RMB Series A Funding Led by Share Investment to Pioneer Premium ENT Specialty Care
Recently, Beidouxing ENT Hospital Group (hereinafter referred to as “Beidouxing Hospital”) announced the completion of its tens-of-millions-of-yuan Series A financing, exclusively invested by Fenxiang Investment.Shenxue Capital served as the financial advisor for this round of investment. Previously, Beidou Star Hospital secured tens of millions of yuan in angel-round financing, led by Weidu Capital and participated in by Xie Li Investment.
Located in Wuhan, Beidou Star Hospital is Hubei Province’s first tertiary-level specialized ENT hospital positioned in the mid-to-high-end market. Specializing in pediatric otorhinolaryngology, its services span seven departments—including Pediatric ENT, Stomatology, Allergy, and Ophthalmology—and six specialized centers. The hospital creates a comfortable and welcoming, five-star hotel-style healthcare environment for children and their families, and collaborates closely with top-tier ENT specialists and hospitals across China to provide members with appointment services for renowned physicians.
Dr. Yao Hongwu, founder of Beidou Star Hospital, stated that this round of financing will be used to strengthen the operations of Wuhan’s first Beidou Star Hospital over the next one to two years, establish a specialist physician group in otolaryngology, and build a data cloud platform.
Xie Kai, Managing Director at Fenxiang Investment, stated that the ENT specialty sector remains a relatively untapped blue ocean. With its clear positioning, Beidou Star Hospital aligns with the trends of new-style healthcare and the upgrade of medical services driven by quality consumption. By fully leveraging the synergistic advantages of its specialized ENT disciplines, the hospital can better build sustainable brand loyalty and competitive barriers.
“Sharing Investment is optimistic about Beidou Star Hospital’s hybrid, practice-oriented team and believes that Beidou Star has great potential to become a leader in the mid-to-high-end ENT specialty healthcare sector, serving as the true guiding ‘North Star’ in this unique niche,” said Xie Kai.
The management team of Beidouxing Hospital combines exceptional operational capabilities with significant industry influence. Dr. Yao Hongwu, the founder, graduated from Tongji Medical College of Huazhong University of Science and Technology. With over a decade of experience in managing specialty hospital chains in otolaryngology, he has accumulated substantial expertise in the operation of large hospital groups, nationwide chain management, and innovative medical services. Professor Wang Zhinan, co-founder, serves as Vice Chairman of the Chinese Society of Otorhinolaryngology, leads a key provincial discipline in Hubei Province, and is the former Director of the Department of Otorhinolaryngology at Wuhan Children's Hospital. He possesses profound expertise in pediatric otorhinolaryngology and extensive experience in cultivating clinical teams. Co-founder He Qingsong brings rich practical experience in media promotion, market expansion, and public relations.
Facing a vast market, Beidou Star Hospital has mastered the expansion strategy of entering through high-quality pediatric services to build a family-wide trust system, with medical quality as its core competitiveness. Since its inception, the hospital has ensured the provision of first-tier domestic pediatric otolaryngology diagnosis and treatment services. The Department of Allergy stands at the forefront of this field in China; partnering with ALK, the Danish global leader in allergens, Beidou Star Hospital has jointly established an International Standardized Desensitization Therapy Center, becoming the only private specialized hospital in China to receive this distinction.
In addition to assembling a highly skilled core medical team, the hospital has created an engaging and joyful one-stop pediatric care environment themed around “Halsey Planet,” which alleviates children’s fear of medical visits and delivers a thoughtful service experience for both children and their parents.
The strategy of leveraging pediatric care to drive family-oriented private ENT (Ear, Nose, and Throat) doctor services has yielded significant results. Since its opening over a year ago, Wuhan’s first Beidouxing Hospital has seen a strong upward trend in both patient visits and revenue within its pediatric department, which in turn has spurred growth across other departments. With the rising demand for high-quality medical services among middle-class families and the gradual realization of the demographic dividend from the two-child policy, Beidouxing Hospital is poised for even greater development opportunities.
In the future, Dr. Yao Hongwu plans to establish more than three specialized chain hospitals within five years, supported by satellite clinics, and to form a coordinated referral network with primary and secondary hospitals as well as general practice clinics, thereby consolidating his leading position in the mid-to-high-end otolaryngology sector.
In recent years, the wave of establishment and expansion of private chain hospitals has been in full swing. Specialized medical service institutions with relatively high consumer attributes, such as dentistry, pediatrics, and medical aesthetics, have emerged in large numbers and flourished, meeting the public’s demand for personalized, high-quality medical services. Meanwhile, they have played a significant role in cultivating the market and enhancing consumers’ awareness of mid-to-high-end healthcare.
Consequently, specialized medical chain services that possess both consumer-oriented attributes and stronger medical characteristics—including otolaryngology specialties—have begun to enter a window period of accelerated development.
Xie Kai, Managing Director at Fenxiang Investment, believes that the patient population in otolaryngology is substantial, with high incidence and recurrence rates driven by various external factors such as environmental conditions and lifestyle choices, which will keep these rates persistently high. Notably, the comprehensive incidence rate and the rigid demand for treatment are most pronounced among children. Otolaryngological conditions exhibit typical characteristics of chronic diseases; however, compared to other chronic conditions, patients’ experience of the quality and efficacy of medical services is more tangible. Coupled with a higher average transaction value, this makes otolaryngology an excellent category for mid-to-high-end specialized medical services.
Outside the existing public healthcare system, private sector participation enables market segmentation and supplementation, addressing the unmet demand among the middle class for high-quality, efficient, and minimally invasive treatment services. This national market in China is projected to reach a scale of hundreds of billions of yuan.
As the policy environment, consumer awareness, and talent supply continue to improve, coupled with opportunities arising from significant advances in minimally invasive techniques, the market’s substantial potential is poised for release. The timing is nearing maturity for identifying high-quality investment targets in the otolaryngology specialty, making it an opportune moment to strategically position oneself in this sector.